These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11737519)

  • 1. CD34 expression in desmoplastic melanoma.
    Hoang MP; Selim MA; Bentley RC; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Nov; 28(10):508-12. PubMed ID: 11737519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
    Boyle JL; Haupt HM; Stern JB; Multhaupt HA
    Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrophic and plaquelike dermatofibrosarcoma protuberans.
    Davis DA; Sánchez RL
    Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
    Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
    Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-rearranged, CD34-positive spindle cell neoplasms resembling dermatofibrosarcoma protuberans: a study of seven cases.
    Agrawal S; Ameline B; Folpe AL; Azzato E; Astbury C; Mentzel T; Knapp C; Rütten A; Creytens D; Sukov W; Baumhoer D; Billings SD; Fritchie KJ
    Histopathology; 2024 Oct; 85(4):649-659. PubMed ID: 38867577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans of the vulva: a mesenchymal tumour with a broad differential diagnosis and review of literature.
    Gilani S; Al-Khafaji B
    Pathologica; 2014 Dec; 106(4):338-41. PubMed ID: 25845051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
    Shah KK; McHugh JB; Folpe AL; Patel RM
    Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature.
    Sheehan DJ; Madkan V; Strickling WA; Peterson CM
    Cutis; 2004 Oct; 74(4):237-42. PubMed ID: 15551716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.